Baker McKenzie
We only have limited information for this firm. Consider the following firms which have provided more information:
Baker McKenzie houses a ‘fast, reliable and professional’ practice, which is known for its ’excellent’ expertise in advising global healthcare and biotech corporations on compliance programs, strategic partnerships, and product regulation. Additionally, the group exhibits broad corporate and IP expertise, handling product acquisition arrangements and technology transfer agreements for medtech clients. The ‘exceptional’ Julie Yeni leads the team, and frequently advises healthcare clients on both contentious and non-contentious matters, particularly in relation to market access, clinical trials, and commercialisation.
Legal 500 Editorial commentary
Testimonials
Collated independently by Legal 500 research team.
‘A fast, reliable and professional team, as always. A big plus to have them by our side.’
‘Julie Yeni is recommended for her precision, clairvoyance, and her experience. An exceptional professional.’
Abbreviated data is displayed for this firm.
Key clients
- AbbVie
- BMS - Bristol-Myers Squibb
Abbreviated data is displayed for this firm.
Work highlights
- Advised New-York-based investment fund New Mountain Capital on the acquisition of the Applied, Food and Enterprise Services (AES) business of the Discovery & Analytical Solutions division of PerkinElmer Inc.
- Advised Johnson & Johnson, in connection with the spin-out of its consumer healthcare business. In France, this internal reorganization is concretized by notably transferring a manufacturing pharmaceutical establishment from one legal entity to a newly created legal entity within the group.
Abbreviated data is displayed for this firm.